Ardelyx Investigative Site 228 — St Louis, Missouri

Ardelyx Investigative Site 228 is a clinical research site located in St Louis, Missouri, United States 63042.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ardelyx Investigative Site 228 has participated in 1 clinical trials.

Therapeutic areas: Constipation Predominant Irritable Bowel Syndrome.

Sponsors: Ardelyx.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ardelyx Investigative Site 228?

Ardelyx Investigative Site 228 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ardelyx Investigative Site 228 conducted?

Ardelyx Investigative Site 228 has 1 clinical trials on record. Their work covers Constipation Predominant Irritable Bowel Syndrome.

Is Ardelyx Investigative Site 228 accredited by Crixeo Health?

Ardelyx Investigative Site 228 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ardelyx Investigative Site 228?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.